Haematologica Issues Research Articles in March 2023 Edition
March 02, 2023
March 02, 2023
PAVIA, Italy, March 2 -- Haematologica, a peer-reviewed journal from the Ferrata-Storti Foundation that says it features hematology, published research articles on the following topics in its March 2023 edition:
Articles:
* Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning
* A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemi . . .
Articles:
* Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning
* A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemi . . .